Investigator Initiated Trials

Investigator Initiated Trials

Allergan is committed to supporting Investigator Initiated Trials (IITs) as a part of the drug discovery and development process. Scientific research that is produced by qualified third-party investigators is key to complementing Allergan-sponsored research to help better understand the benefit/risk profile of our therapies as well as explore new opportunities to address unmet medical needs.

Allergan defines IITs as studies developed and sponsored by an independent investigator or academic sponsor. Allergan requires that clinical research undertaken through IITs be based on the need to address meaningful scientific and/or clinical objectives supported by valid scientific designs while respecting the privacy rights, safety and welfare of patients.

An IIT may be either a clinical or non-clinical study, conducted without the participation of Allergan for which the sponsor has requested that Allergan provide funding, drug product or both. Allergan provides financial support and/or drug product for IITs according to a written agreement, which requires that third-party sponsors comply with applicable local laws and regulatory requirements.

Begin the Allergan Investigator Initiated Trials application process